Global sodium hyaluronate-based products market to reach USD 14.3 billion by 2027. Global sodium hyaluronate-based products market is valued approximately at USD 8.6 billion in 2020 and is anticipated to grow with a healthy growth rate of about 7.5% over the forecast period 2021-2027. Sodium hyaluronate is like the fluid that surrounds joints in the body. The fluid acts as a shock absorber and lubricant for the joints. Sodium hyaluronate-based products are used for the treatment of knee pain caused by osteoarthritis and is often given to the patients when other medications for arthritis have not been effective. The global sodium hyaluronate-based products market is being driven by increasing prevalence of non-healing wounds and increasing geriatric population and prevalence of osteoarthritis & eye diseases. Furthermore, growing demand for minimally invasive cosmetic procedures will provide new opportunities for the global sodium hyaluronate-based products industry. For instance, according to Statista, the total market revenue of minimally invasive surgery across the globe is expected to increase from USD 20.5 billion in 2019 to approximately USD 44 billion by 2030. Such growth in the market revenue share of minimally invasive surgery across the globe is expected to increase the demand and adoption of sodium hyaluronate-based products to provide faster incision healing and hence this is expected to boost the market growth. However, high cost of injection cycles may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global sodium hyaluronate-based products market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America accounts for the largest share in terms of market revenue in the global sodium hyaluronate-based products market over the forecast period 2021-2027. Factors such as high healthcare expenditure in countries such as the United States and Canada, high number of dermal filler procedures performed across the region, rising geriatric population, technological advancements and developments, etc. contribute towards the largest market share of the region in the forecast years.

Major market player included in this report are:
Allergan, Inc. (a part of AbbVie, Inc.)
Galderma S.A.
Bohus BioTech AB
LG Chem Ltd.
Syner-Med (Pharmaceutical Products) Ltd.
Anika Therapeutics Inc.
Cadila Pharmaceuticals Ltd.
Ferring Pharmaceuticals B.V.
Fidia Farmaceutici S.p.A.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Topical
Injectable
Others
By Application:
Pharmaceuticals
Cosmetics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Sodium Hyaluronate-based Products Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors